: $Actelis Networks(ASNS)$ 中概退潮,玩你们俩兄弟够了,神经病一样的庄,疯狂的手法查看全文
usbiostock2018-06-28 19:46
$Arsanis, Inc.(ASNS)$ 公司宣布ASN100预防金黄色葡萄球菌肺炎临床2期试验未能达到主要终点,公司将终止该药的研发。公司重点将放在ASN500,用于预防呼吸道合胞病毒感染。查看全文
美股医药Z博士2017-12-12 11:33
$Arsanis, Inc.(ASNS)$ 来推荐一只IPO不久的股票,喜欢短线的朋友可以关注。公司具有很多极具潜力的单抗抗生素药物,目前股价已跌破发行价。今日两大投行提高它的评级,并给出23的目标价,结果有意思的是股价居然-12%。是个不错的短线机会,第一个目标价16左右。查看全文
$Arsanis(ASNS)$ 8-K - Current report Filed: 2019-04-02 AccNo: 0001193125-19-095201 Size: 19 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Arsanis(ASNS)$ 8-K - Current report Filed: 2019-04-01 AccNo: 0001193125-19-093803 Size: 8 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Arsanis(ASNS)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-03-25 AccNo: 0001193125-19-085450 Size: 100 KB 网页链接
$Arsanis(ASNS)$ SC 13D - General statement of acquisition of beneficial ownership Filed: 2019-03-22 AccNo: 0001193125-19-083526 Size: 53 KB 网页链接
$Arsanis(ASNS)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-03-19 AccNo: 0000947871-19-000210 Size: 123 KB 网页链接
$Arsanis(ASNS)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-03-15 AccNo: 0000898432-19-000393 Size: 95 KB 网页链接
$Arsanis(ASNS)$ 美东时间 2019-03-14 拆合股: 6合1 网页链接
$Arsanis(ASNS)$ 8-K - Current report Filed: 2019-03-13 AccNo: 0001193125-19-073465 Size: 2 MBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registra...
$Arsanis(ASNS)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-03-11 AccNo: 0001193125-19-070143 Size: 66 KB 网页链接
$Arsanis(ASNS)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2019-03-11 AccNo: 0001564590-19-007097 Size: 12 MB 网页链接